Cargando…
TROP-2, Nectin-4, GPNMB, and B7-H3 Are Potentially Therapeutic Targets for Anaplastic Thyroid Carcinoma
SIMPLE SUMMARY: Anaplastic thyroid carcinoma is a highly aggressive thyroid tumor with a poor prognosis. There are limited choices for the effective treatment of this type of carcinoma. Whether the targets of antibody–drug conjugates are expressed in anaplastic thyroid carcinoma remains unclear. The...
Autores principales: | Toda, Soji, Sato, Shinya, Saito, Nao, Sekihara, Kazumasa, Matsui, Ai, Murayama, Daisuke, Nakayama, Hirotaka, Suganuma, Nobuyasu, Okubo, Yoichiro, Hayashi, Hiroyuki, Iwasaki, Hiroyuki, Miyagi, Yohei, Hoshino, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833363/ https://www.ncbi.nlm.nih.gov/pubmed/35158847 http://dx.doi.org/10.3390/cancers14030579 |
Ejemplares similares
-
Lenvatinib vs. palliative therapy for stage IVC anaplastic thyroid cancer
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020) -
Invasive procedures in patients undergoing treatment with lenvatinib for thyroid cancer
por: Toda, Soji, et al.
Publicado: (2021) -
Three Cases of Anaplastic Thyroid Carcinoma Transformation and Leukocytosis during Lenvatinib Treatment
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020) -
Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report
por: Toda, Soji, et al.
Publicado: (2021) -
Ovarian goiter detected during post-operative follow-up of papillary thyroid cancer: a case report
por: Murayama, Daisuke, et al.
Publicado: (2023)